How the Use of Psilocybin Mushrooms for Cancer Patients work

Psilocybin is a compound found in psychedelic mushrooms so the name psilocybin mushrooms. Studies from research institutes, and universities show that a single dose of psilocybin improves a cancer patients’ emotional state. It is a great breakthrough as most cancer patients are mostly depressed for getting sick, and their medication causes this depression and anxious side effects. 

This article will tell how the use of psilocybin mushrooms for cancer patients works by first giving results to two researchers. 

Results on study done in 2016 indicated that combinations of Psilocybin and psychotherapeutic sessions made substantial improvements in depression and anxiety found among cancer patients. 29 cancer patients participated in the study. In six months, 60-80% of the participants recorded a significant reduction in depression and anxiety and developed a positive attitude about death. Five years later, a follow-up done revealed that 70% of the participants confirmed the use of Psilocybin brought about positive long-term changes in their lives like spiritual, psychological, and personal. 

Stephen led another research study in a lab staged like a living room with flowers, pictures, and piece of art. The patients put on headphones with some comforting music on, and the psychedelic drug injected into their bloodstream. The outcome was immediate and prolonged improvements in depression and anxiety. 

So how does it work? 

Research shows that Psilocybin or magic mushrooms works on cancer patients by targeting a brain network known as the default mode network. This network gets activated upon engaging in mind wandering and self-reflection activities. In cancer patients, this network causes them to start self-worry and self-pity that in turn causes depression and anxiety. When Psilocybin is administered, it acts as a temporary default mode network shifting a patients’ focus to a broader picture of her/his life and not the disease. Psilocybin does this by invoking a spiritual situation of one with the universe by rising brains’ entropy and reducing the self-thinking, and self-sustaining ego of the network in default mode ‘default mode network’. In simpler terms, psychedelic drugs make a cancer patient forget that he/she is sick by shifting focus on other things. 

How does it achieve its mission? 

Psilocybin is a chemical compound similar to brain-produced neurotransmitter serotonin. These serotonin functions include responsible for someones’ perception and moods. Psilocybin mimics these serotonin neurotransmitters and exerts its function of causing brain entropy on its subject. 

The other crucial attack of Psilocybin is the temporal lobe of the brain, associated with memory and emotions. 

Today, contrary to Psilocybin mushrooms hazardous reputation three trials show that Psilocybin is safe for use in clinical settings. And unlike other medications and therapies, Psilocybin is proven to create an immediate shift of demoralization and meaninglessness found in cancer patients. 

Thomas L. Kerr

 brian@intltaxcounselors.com  

Related Post

MAGIC MUSHROOMS: A POTENTIAL ALLY IN CANCER PATIENT CARE MAGIC MUSHROOMS: A POTENTIAL ALLY IN CANCER PATIENT CARE 

  1. Introduction to Psilocybin and Its Therapeutic Uses

Psilocybin is a naturally occurring compound found in over 200 species of fungi, colloquially known as magic mushrooms. Used for centuries by indigenous cultures in religious and healing rituals, its psychoactive properties have recently become a focus of modern medical research Click Here For more Info. Psilocybin has been studied in various therapeutic contexts, including as a potential aid for cancer patients.

Research on psilocybin as a treatment for mental health conditions has shown promise, leading to its reclassification in some countries as a Schedule-2 drug, meaning it has recognized medical benefits. For instance, studies have suggested its effectiveness in treating depression, post-traumatic stress disorder, and addiction.

  1. Psilocybin and Cancer-Related Distress

Among the debilitating side effects of cancer and its treatment, psychological distress is one of the most profound, often leading to severe depression and anxiety. In this context, psilocybin has shown significant potential to alleviate these symptoms.

In a 2016 study published in the Journal of Psychopharmacology, patients with life-threatening cancer diagnoses reported reduced symptoms of depression and anxiety after just a single dose of psilocybin. This reduced psychological distress was found to last for up to six months, suggesting that psilocybin could provide long-term relief for cancer patients.

  1. The Mechanism of Action of Psilocybin

So, how does psilocybin work? The compound is psychedelic, which means it works primarily by binding to serotonin receptors in the brain. This can induce profound changes in consciousness, often characterized by unity, interconnectedness, and a transcendence of time and space.

This altered state of consciousness can help cancer patients reframe their experiences and fears about their illnesses. Some patients describe these experiences as profoundly spiritual or mystical, leading to insights that help them confront their mortality and find peace with their situation. This way, psilocybin-assisted therapy can offer psychological relief that traditional treatments might not provide.

  1. The Future of Psilocybin in Cancer Care

Given these promising results, researchers are now focused on further understanding the therapeutic potential of psilocybin and finding ways to integrate it safely into standard cancer care. Despite the progressive reclassification in some regions, psilocybin remains a Schedule-1 drug under U.S. federal law, indicating that it has no officially recognized medical use and a high potential for abuse.

However, as public opinion shifts and scientific evidence continues to mount, there is a growing hope that psilocybin will play an increasing role in cancer care, especially in managing the psychological distress associated with the disease. It’s essential to note that while the initial research is promising, psilocybin is not a cure for cancer but a potential tool to help manage its psychological effects.

In conclusion, magic mushrooms may offer more than their mystical reputation suggests. As psilocybin research continues, the substance’s potential as an aid in cancer care is becoming more apparent. The following years may see this natural compound playing an integral part in revolutionizing cancer patient care, alleviating mental distress and improving the overall quality of life for those facing this challenging disease.

Thomas L. Kerr

 brian@intltaxcounselors.com  
Magic mushroom dispensary

THINGS YOU NEED TO KNOW ABOUT MICRO-DOSING MAGIC MUSHROOMTHINGS YOU NEED TO KNOW ABOUT MICRO-DOSING MAGIC MUSHROOM

Magic mushroom is one of the fungi that have been making an impact in the field of medicine. It contains a naturally occurring extract called psilocybin, a psychoactive ingredient. In previous years, people have been consuming doses of psilocybin with adverse side effects, including hallucination, which resulted in it being classified as a drug of abuse. However, Micro-dosing Magic Mushroom psilocybin has made doctors dispute this.

What is Micro-dosing?

Scientifically, the dosage is classified as overdosing, dosing, under-dosing, micro-dosing, etcetera. Micro-dosing is the consumption of tiny quantities of psychedelic drugs, and Micro-dosing can only amount to up to 10% of the total dose. It ranges from 100 to 300 milligrams of dried magic mushrooms about two to five times a week. 

What Can Micro-Dosing Do?

After a long time of considering psilocybin as a drug of abuse, scientists opted to research to find out if there could be other ways psilocybin could be helpful. Research on those dosing was drawn to the conclusion that it had adverse effects. They also did a trial on the individuals and those not using it. The situation of those dosing with psilocybin worsened than those who did not use any.

Another approach was derived from Micro-dosing Magic mushrooms. It involved using minimal quantities on people with depression, anxiety, and mental disorders. After observing them for some time, they noticed many changes with huge improvements compared to those who did not take the dosage.

They showed signs of stability mentally, almost non-depressed with no anxiety. It drove them to the conclusion that the micro-dosing was more effective.

What Are The Variations in micro-Dosing?

Micro-dosing was done on individuals of both genders, and the results were varied. There were unique observations in females compared to males. The Micro-dosing Magic Mushroom was more effective in females than males under the exact dose size, and the results indicated that it works better with females than males. 

How Is Micro Dosing Effective?

The magic mushroom proved to be effective with reduced dose sizes. It should be considered when dealing with depression and other mental disorders. However, the dosing should not be frequent to avoid harming the depressed. If you live in Quebec and are looking for some micro dosing products you can Find Magic Mushrooms in Montreal Here 

It is best to seek medical advice before opting to consume magic mushrooms. Also, they should make strict observations of the depressed by monitoring their progress, which will help to determine whether it impacts positively or negatively.

Conclusion

Magic mushrooms can treat depression when correctly micro-dosed under strict observations.

Thomas L. Kerr


 brian@intltaxcounselors.com


 

CHOCOLATES WITH A TWIST: THE THERAPEUTIC POTENTIAL OF MAGIC MUSHROOM TREATS CHOCOLATES WITH A TWIST: THE THERAPEUTIC POTENTIAL OF MAGIC MUSHROOM TREATS 

Many people search for new ways to tackle stress and depression. Psilocybin, found in magic mushrooms, shows promise in mental health treatments Click Here. This article dives into how chocolate treats infused with psilocybin could change the future of therapy. 

Discover a sweet path to wellness! 

The Therapeutic Potential of Magic Mushroom Treats 

Psilocybin chocolates have been gaining attention for their potential as a treatment for mental health conditions, with reported benefits including reduced anxiety and depression. However, the legal status and concerns surrounding magic mushroom treats remain a topic of debate. 

Psilocybin chocolates as a potential treatment for mental health conditions 

Magic mushroom treats like psilocybin-infused chocolates are being looked at as a way to help with mental health conditions. These chocolates mix the healing properties of magic mushrooms with the taste of cocoa. 

People are getting excited because they could be a new form of treatment for things like sadness, worry, and stress. Doctors are studying these tasty shroom alternatives to see how they can change the mind in good ways. 

Shroom enthusiasts find that these psychedelic mushroom chocolate bars might make their minds clearer and moods better. Eating these magic mushroom treats could give benefits similar to traditional psychedelic therapy but in a much more enjoyable form. 

While raw magic mushrooms have a strong taste that some people don’t like, pairing them with cacao makes it easier for patients to take part in this alternative medicine approach. 

Reported benefits of psilocybin therapy 

Psilocybin therapy shows promise for helping with mental health issues. People who have used it report feeling less anxious and depressed after treatment. Some also say they’ve had meaningful, spiritual experiences that changed how they see the world. 

Research suggests that psilocybin could help treat conditions like depression, anxiety, and PTSD, offering hope to those who haven’t found relief from traditional therapies. 

The results of studies on Psilocybin therapy look positive so far, but it’s important to remember more research is needed before conclusions can be drawn. However, early findings point toward its potential as a breakthrough treatment for various mental health challenges. 

Legal status and concerns surrounding magic mushroom treats 

Psilocybin-infused chocolates, while potentially offering therapeutic benefits, face legal challenges due to their association with hallucinogenic effects. The grey market status of these edible mushrooms raises concerns about the quality and safety of such products for consumers. 

Moreover, the classification of psilocybin as a mind-altering drug adds complexity to its legality in many jurisdictions. 

As an online dispensary client, it’s important to stay informed about the legal status and potential risks associated with magic mushroom treats. While recognizing their possible therapeutic effects, it’s crucial to navigate these products responsibly within the current legal framework and consider ethical implications surrounding their production and consumption. 

The Future of Magic Mushroom Treats 

Current research on psilocybin therapy is showing promising results, leading to discussions about the potential for legalization and regulation of magic mushroom treats. Ethical considerations for the production and consumption of these mind-altering substances are also being raised as their popularity grows. 

Current research on psilocybin therapy 

Recent studies have shown promising results in using psilocybin therapy to treat mental health conditions. Research suggests that this mind-altering substance, found in magic mushrooms, may offer therapeutic effects for depression, anxiety, and PTSD. 

Psychedelic-assisted therapy involving psilocybin is being explored as a potential breakthrough in mental health treatment. These findings highlight the growing interest in harnessing the therapeutic potential of psychedelics like psilocybin for addressing various mental health challenges. 

As the research on psilocybin therapy advances, it opens up new possibilities for innovative treatment options beyond traditional pharmaceuticals and therapy techniques. The growing body of evidence supporting the use of psychedelics presents an exciting frontier for mental health care. 

Potential for legalization and regulation 

The potential for legalization and regulation of psilocybin-infused chocolates is gaining attention. Current research on psilocybin therapy is paving the way for a possible shift in legal status, moving it from the “party drug” category to a regulated therapeutic option. 

Ethical considerations surrounding the production and consumption of these magic mushroom treats are also being discussed. The conversations about legalization, regulation, and ethical aspects are shaping the future landscape of these mind-altering substances. 

Several factors are contributing to discussions about legalizing and regulating psilocybin-infused chocolates. The reported therapeutic effects of psychedelics highlight their potential as legitimate treatment options for mental health conditions. 

As research continues to explore the benefits of psychedelic-assisted therapy, there is increasing interest in creating frameworks that could allow safe access while mitigating potential risks associated with their use. 

Ethical considerations for the production and consumption of magic mushroom treats 

When considering the production and consumption of magic mushroom treats, it’s essential to prioritize ethical sourcing and manufacturing practices. This includes ensuring that the mushrooms used are obtained responsibly and sustainably, without causing harm to the environment or communities. 

Furthermore, transparent labeling and accurate dosing information are crucial for consumers to make informed decisions about their consumption. It’s important for producers to prioritize consumer safety and well-being by providing clear guidance on responsible use and potential risks. 

Looking ahead at the future of magic mushroom treats, it’s vital for both producers and consumers to advocate for regulations that prioritize safety, quality, and ethical considerations in the production and consumption of these products. 

Conclusion 

In conclusion, the therapeutic potential of magic mushroom treats, particularly psilocybin-infused chocolates, offers promising prospects for mental health treatment. As research on psychedelic-assisted therapy advances, the future may hold opportunities for their legalization and regulation. 

However, ethical considerations regarding production and consumption of these mind-altering substances will be pivotal in shaping their role in the post-pandemic era. 

Thomas L. Kerr

 brian@intltaxcounselors.com